All Stories

  1. To Explore Potential Natural Inhibitors of Cysteine Proteases to Combat Human African Trypanosomiasis and Chagas Disease

    Article • Current Medicinal Chemistry, April 2026, Bentham Science Publishers

    ALOKE SAHA, Dr Sisir Nandi

  2. Formulation, Optimization and Design of Capecitabine Nanosuspension to Enhance the Anti-Gastric Cancer Efficacy using Box-Behnken Quality-based Design Study

    Article • Current Drug Discovery Technologies, January 2026, Bentham Science Publishers

    Harekrishna Roy, Dr Sisir Nandi

  3. Quantitative Structure-Activity-Amino Acid Relationship of Benzodiazepines and Thienodiazepine via Molecular Docking Simulation

    Article • Current Drug Discovery Technologies, October 2025, Bentham Science Publishers

    Dr Sisir Nandi

  4. To Combat Abnormal Cell Signaling Mediated Gastrointestinal Cancer by Therapeutic Modulation of Gut Microbiota Utilizing Prebiotics, Postbiotics, and Synbiotics

    Article • Current Cancer Drug Targets, July 2025, Bentham Science Publishers

    Dr Sisir Nandi

  5. To Explore Potential Inhibitors against Various Enzymatic Targets of Human African Trypanosomiasis

    Article • Combinatorial Chemistry & High Throughput Screening, June 2025, Bentham Science Publishers

    Dr Sisir Nandi

  6. To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds

    Article • Current Medicinal Chemistry, July 2024, Bentham Science Publishers

    Arnob Chakrovorty, Dr Sisir Nandi

  7. Exploring the Biochemical Mechanisms of Fluoroquinolone Compounds against Tuberculosis by Utilizing Molecular Docking and Quantitative Structure-amino Acid Relationship

    Article • Letters in Drug Design & Discovery, July 2024, Bentham Science Publishers

    muneer alam siddiqui, Dr Sisir Nandi

  8. QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical Molecular Descriptors

    Article • Letters in Drug Design & Discovery, January 2024, Bentham Science Publishers

    Professor Anil Kumar Saxena, Assistant Professor MOHIT KUMAR, Dr Sisir Nandi

  9. Exploring the SARS-Cov-2 Main Protease (Mpro) and RdRp Targets by Updating Current Structure-based Drug Design Utilizing Co-crystals to Combat COVID-19

    Article • Current Drug Targets, June 2022, Bentham Science Publishers

    Dr Sisir Nandi, Rashmi Rashmi

  10. Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking

    Article • Letters in Drug Design & Discovery, May 2022, Bentham Science Publishers

    Dr Sisir Nandi, Assistant Professor MOHIT KUMAR, Professor Anil Kumar Saxena

  11. Exploring Current Role of Nanotechnology Used in Food Processing Industry to Control Food Additives and their Biochemical Mechanisms

    Article • Current Drug Targets, April 2022, Bentham Science Publishers

    Dr Sisir Nandi

  12. Natural Sourced Traditional Indian and Chinese Medicines to Combat COVID-19

    Article • March 2022, Bentham Science Publishers

    Professor Anil Kumar Saxena, Dr Sisir Nandi

  13. Exploring the Abnormal Signal Transduction Mediated Internet Addiction and Gaming Disorders

    Article • Current Signal Transduction Therapy, December 2021, Bentham Science Publishers

    Dr Sisir Nandi, Bhumika Chauhan

  14. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents

    Article • Current Drug Targets, November 2021, Bentham Science Publishers

    Harekrishna Roy, Dr Sisir Nandi, Professor Anil Kumar Saxena, Asha Gummadi

  15. Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment

    Article • Current Topics in Medicinal Chemistry, October 2021, Bentham Science Publishers

    Harekrishna Roy, BHABANI SHANKAR NAYAK, Dr Sisir Nandi, Professor Anil Kumar Saxena

  16. Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors

    Article • Current Topics in Medicinal Chemistry, August 2021, Bentham Science Publishers

    Dr Sisir Nandi, Professor Anil Kumar Saxena

  17. The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking

    Article • Combinatorial Chemistry & High Throughput Screening, June 2021, Bentham Science Publishers

    Assistant Professor MOHIT KUMAR, Dr Sisir Nandi, Professor Anil Kumar Saxena

  18. Phyto-chlorophyllin prevents alloxan-induced toxicity

    Article • Combinatorial Chemistry & High Throughput Screening, December 2020, Bentham Science Publishers

    Dr Sisir Nandi, Pradeepta Guptaroy, Arnob Chakrovorty

  19. A Quality by Design Approach of Metronidazole Bigel and Assessment of Antimicrobial Study Utilizing Box-Behnken Design

    Article • Combinatorial Chemistry & High Throughput Screening, December 2020, Bentham Science Publishers

    Dr Sisir Nandi, Harekrishna Roy, Sudhir Maddela

  20. In Silico Factorial Screening and Optimization of Chitosan Based Gel for Urapidil Loaded Microparticle using Reduced Factorial Design

    Article • Combinatorial Chemistry & High Throughput Screening, December 2020, Bentham Science Publishers

    Harekrishna Roy, BHABANI SHANKAR NAYAK, Dr Sisir Nandi

  21. Current Development on Chitosan-based Antimicrobial Drug Formulations for the Wound Healing

    Article • Current Drug Discovery Technologies, September 2020, Bentham Science Publishers

    Harekrishna Roy, Dr Sisir Nandi

  22. Abnormal Signal Transduction via Over-expression of Pim-1 Regulated Senescence, Cell Cycle, Apoptosis and Metastatic Invasion: Novel Anticancer Targets and Their Potent Inhibitors from Marine Sources

    Article • Current Signal Transduction Therapy, July 2020, Bentham Science Publishers

    Dr Sisir Nandi

  23. To Explore the Potential Targets and Current Structure-based Design Strategies Utilizing co-crystallized Ligand to Combat HCV

    Article • Current Drug Targets, July 2020, Bentham Science Publishers

    Harekrishna Roy, Dr Sisir Nandi, Bhumika Chauhan

  24. Computer aided chitosan anchor nanoparticles

    Article • Current Pharmaceutical Design, May 2020, Bentham Science Publishers

    Harekrishna Roy, Dr Sisir Nandi, BHABANI SHANKAR NAYAK

  25. QSAR and molecular docking studies of lethal factor protease inhibitors against Bacillus anthracis

    Article • SAR and QSAR in Environmental Research, September 2019, Taylor & Francis

    Dr Sisir Nandi, Professor Anil Kumar Saxena

  26. Identification of Therapeutically Active Molecules against Anthrax through Structure and Ligand based Drug Design

    Article • Current Topics in Medicinal Chemistry, January 2019, Bentham Science Publishers

    Dr Sisir Nandi, Professor Anil Kumar Saxena

  27. Zika virus. Zika Viral Targets. Synthetic and Natural Sourced Inhibitors.

    Article • Current Topics in Medicinal Chemistry, December 2018, Bentham Science Publishers

    Dr Sisir Nandi, Assistant Professor MOHIT KUMAR, Ramandeep Kaur, Professor Subhash C Mandal

  28. Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads

    Article • Current Signal Transduction Therapy, September 2018, Bentham Science Publishers

    Dr Sisir Nandi, Mohd Salman, Assistant Professor MOHIT KUMAR

  29. Recent Trends in Design and Developments of New Drugs for the Treatment of Cancer, Rheumatoid arthritis, and Parkinson’s Disease-Associated to Abnormal Signal Transduction

    Article • Current Signal Transduction Therapy, September 2018, Bentham Science Publishers

    Dr Sisir Nandi

  30. Current Drug Design Strategies for Fighting Against Swine Influenza

    Article • Current Drug Therapy, September 2017, Bentham Science Publishers

    Dr Sisir Nandi, muneer alam siddiqui

  31. Recent Advances in Ligand and Structure Based Screening of Potent Quorum Sensing Inhibitors Against Antibiotic Resistance Induced Bacterial Virulence

    Article • Recent Patents on Biotechnology, October 2016, Bentham Science Publishers

    Dr Sisir Nandi

  32. In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors

    Article • SpringerPlus, December 2015, Springer Science + Business Media

    Dr Sisir Nandi

  33. In silico evaluation of 6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7(8H)-one compounds: an insight into design of less toxic anticancer drugs

    Article • Medicinal Chemistry Research, October 2015, Springer Science + Business Media

    Dr Sisir Nandi

  34. QSAR and structure based design of selective GABA-A receptor antagonists

    Article • Research and Reports in Medicinal Chemistry, October 2015, Dove Medical Press

    Dr Sisir Nandi, Dr Sisir Nandi, Mohd Salman

  35. QSAR and Drug Design

    Article • Current Computer - Aided Drug Design, September 2015, Bentham Science Publishers

    Dr Sisir Nandi

  36. QSAR and pharmacophore modeling of indole-based C-3 pyridone compounds as HCV NS5B polymerase inhibitors utilizing computed molecular descriptors

    Article • Medicinal Chemistry Research, December 2014, Springer Science + Business Media

    Dr Sisir Nandi

  37. QSAR modeling of 4-anilinofuro[2,3-b]quinolines: an approach to anticancer drug design

    Article • Medicinal Chemistry Research, September 2013, Springer Science + Business Media

    Dr Sisir Nandi

  38. Formulation of saquinavir mesylate loaded microparticle by counterion induced aggregation method: Approach by hyperosmotic technique

    Article • Drug Invention Today, September 2013, Elsevier

    Dr Sisir Nandi, Harekrishna Roy

  39. Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers

    Article • International Journal of Applied and Basic Medical Research, January 2013, Medknow

    Dr Sisir Nandi, Harekrishna Roy

  40. Quantitative structure-activation barrier relationship modeling for Diels-Alder ligations utilizing quantum chemical structural descriptors

    Article • Chemistry Central Journal, January 2013, Springer Science + Business Media

    Dr Sisir Nandi

  41. Importance of Kier-Hall Topological Indices in the QSAR of Anticancer Drug Design

    Article • Current Computer - Aided Drug Design, April 2012, Bentham Science Publishers

    Dr Sisir Nandi

  42. Design of fast dissolving amlodipine besylate tablet formulations

    Article • Asian Journal of Pharmaceutics, January 2012, Medknow

    Dr Sisir Nandi, Harekrishna Roy

  43. Activity Prediction of Some Nontested Anticancer Compounds Using GA-Based PLS Regression Models

    Article • Chemical Biology & Drug Design, August 2011, Wiley

    Dr Sisir Nandi

  44. In silicodesign of potent EGFR kinase inhibitors using combinatorial libraries

    Article • Molecular Simulation, March 2011, Taylor & Francis

    Dr Sisir Nandi

  45. QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: Anticancer drug design by computed descriptors

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, April 2009, Taylor & Francis

    Dr Sisir Nandi

  46. 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design

    Article • Molecular Diversity, March 2009, Springer Science + Business Media

    Dr Sisir Nandi

  47. Anticancer Activity of Selected Phenolic Compounds: QSAR Studies Using Ridge Regression and Neural Networks

    Article • Chemical Biology & Drug Design, November 2007, Wiley

    Dr Sisir Nandi

  48. QSAR Analysis of BABQ compounds via calculated molecular descriptors

    Article • Medicinal Chemistry Research, April 2007, Springer Science + Business Media

    Dr Sisir Nandi